Biomarker-guided targeted therapy in lung adenocarcinoma: A concise review of precision oncology advances, resistance mechanisms, and emerging strategies
Biomarker-guided targeted therapy in lung adenocarcinoma: A concise review of precision oncology advances, resistance mechanisms, and emerging strategies. // Pathology - Research and Practice. – URL: https://www.sciencedirect.com/science/article/pii/S034403382600364X?dgcid=rss_sd_all
Biomarker-guided targeted therapy in lung adenocarcinoma: A concise review of precision oncology advances, resistance mechanisms, and emerging strategies. Pathology - Research and Practice. https://www.sciencedirect.com/science/article/pii/S034403382600364X?dgcid=rss_sd_all
“Biomarker-guided targeted therapy in lung adenocarcinoma: A concise review of precision oncology advances, resistance mechanisms, and emerging strategies.” Pathology - Research and Practice.
@article{article90436,
title = {Biomarker-guided targeted therapy in lung adenocarcinoma: A concise review of precision oncology advances, resistance mechanisms, and emerging strategies},
journal = {Pathology - Research and Practice},
url = {https://www.sciencedirect.com/science/article/pii/S034403382600364X?dgcid=rss_sd_all}
}
ABSTRACT High‐dimensional flow cytometry measures immune cells at single‐cell resolution, enabling systematic characterization of cell populations at scale. But harnessing this potential requires seamless interoperability between the...
Abstract The intraneuronal accumulation of amyloid‐β (Aβ) is an early pathogenic event in Alzheimer's disease (AD), initiating a pathological cascade that includes synaptic dysfunction, metabolic deficits, and eventual neuronal loss....